Skip to main content
Lareb logo Menu icon
  • News updates
  • Publications and overviews
  • Education and patient reporting
  • Teratology Information Service (TIS)
  • About Lareb
  • Research and collaborations
  • Contact
Lareb logo
  • About Lareb
  • Contact
Menu icon
Meld een bijwerking van een:
/media/1auhenje/banner-homepage-2.png
  • Home
  • News updates
  • Fatigue associated with biologics

Fatigue associated with biologics

12-04-2023

Fatigue is a common symptom in patients with inflammatory immune diseases. Patients may also experience fatigue as an adverse drug reaction of biologics used for an immune-mediated inflammatory disease. This was reported by participants in the Dutch Biologic Monitor, a longitudinal observational cohort study using the Lareb Intensive Monitoring (LIM) system.

Many patients reporting fatigue as an adverse drug reaction described episodes of fatigue specifically during or shortly after injecting the biologic. This often recurred following subsequent injections. Sometimes it also occurred before injection.

Many factors contribute to fatigue in patients with chronic immune diseases. Evaluating the clinical pattern of fatigue may help in understanding the potential contribution of a biologic in patients experiencing fatigue.

Read the full paper in BioDrugs here.

Pharmacovigilance Centre Lareb
  • About Lareb
  • Research and collaborations
  • Contact
Search
  • News updates
  • Publications and overviews
More about
  • Education and patient reporting
  • Teratology Information Service (TIS)
logo
© Lareb. All Rights Reserved. 2025
Dutch | Cookies | Privacy | Disclaimer
Pharmacovigilance Centre Lareb
  • About Lareb
  • Research and collaborations
  • Contact
Search
  • News updates
  • Publications and overviews
More about
  • Education and patient reporting
  • Teratology Information Service (TIS)
logo
© Lareb. All Rights Reserved. 2025
Dutch | Cookies | Privacy Disclaimer

Dat spijt ons. Kun je ons vertellen wat er niet werkte voor jou?

Toelichting